Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), End-User (Academic & Research Institutions, Contract Research Organizations, Pharmaceutical & Biotechnology) - Global Forecast 2024-2030

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), End-User (Academic & Research Institutions, Contract Research Organizations, Pharmaceutical & Biotechnology) - Global Forecast 2024-2030


The Phosphoramidite Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 7.49% to reach USD 2.13 billion by 2030.

Global Phosphoramidite MarketPhosphoramidite is a class of compounds commonly used to synthesize nucleic acids, such as DNA and RNA, during solid-phase oligonucleotide synthesis. Phosphoramidites are organic phosphorus compounds that contain a phosphorus atom bonded to an amino group through a nitrogen atom and various protecting groups to control reactivity. Growing genomics research activities with the advent of high-throughput sequencing technologies and the need for studying genetic information on a large scale are expanding the usage of phosphoramidite. Increasing focus on personalized medicine that aims to provide tailored healthcare solutions based on an individual's genetic makeup elevates the demand for phosphoramidite. High cost and scalability associated with phosphoramidite hampers market growth. Continuous advancements in synthesis methods and phosphoramidite techniques present opportunities for improvement in efficiency, yield, and cost-effectiveness.

Regional Insights

The presence of well-established pharmaceutical and biotechnology industries, particularly in the United States and Canada, drives the demand for phosphoramidites as essential building blocks in synthesizing nucleic acid-based therapeutics and research tools. Regulatory agencies, including the FDA in the United States, provide guidelines and support for the development of nucleic acid-based therapeutics, which facilitates the adoption of phosphoramidites in the region and encourages market growth. Increasing personalized medicine initiatives, which aim to provide tailored healthcare solutions based on an individual's genetic information, is expected to create opportunities for phosphoramidite manufacturers in the EMEA market. Governments in the Asia-Pacific region actively support the development of their biotechnology and life sciences sectors through various initiatives and funding programs. For instance, China has launched the Made in China 2025 initiative to promote the development of advanced manufacturing, including biotechnology. Government support and funding facilitate research and development activities, creating opportunities for phosphoramidite manufacturers to collaborate and contribute to the market's growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Phosphoramidite Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Phosphoramidite Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC, Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Hongene Biotech Corporation, Huaren Science and Technology Co., Ltd., Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Limited, Lumiprobe Corporation, Maravai LifeSciences, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., SBS Genetech Co., Ltd., STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
DNA Phosphoramidites
Dye-Labeled Phosphoramidites
RNA Phosphoramidites
Speciality Phosphoramidites
End-User
Academic & Research Institutions
Contract Research Organizations
Pharmaceutical & Biotechnology
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Phosphoramidite Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Phosphoramidite Market?
3. What are the technology trends and regulatory frameworks in the Phosphoramidite Market?
4. What is the market share of the leading vendors in the Phosphoramidite Market?
5. Which modes and strategic moves are suitable for entering the Phosphoramidite Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Phosphoramidite Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for oligonucleotides in genetic research, diagnostics, therapeutics, and biotechnology
5.1.1.2. Continuous advancements in genomics research with the advent of sequencing technologies
5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
5.1.2. Restraints
5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
5.1.3. Opportunities
5.1.3.1. Continuous advancements in synthesis methods and techniques for phosphoramidites
5.1.3.2. High potential owing to rising advancements in personalized medicine
5.1.4. Challenges
5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Phosphoramidite Market, by Type
6.1. Introduction
6.2. DNA Phosphoramidites
6.3. Dye-Labeled Phosphoramidites
6.4. RNA Phosphoramidites
6.5. Speciality Phosphoramidites
7. Phosphoramidite Market, by End-User
7.1. Introduction
7.2. Academic & Research Institutions
7.3. Contract Research Organizations
7.4. Pharmaceutical & Biotechnology
8. Americas Phosphoramidite Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Phosphoramidite Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Phosphoramidite Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Agreement, Collaboration, & Partnership
11.3.1.1. Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AAT Bioquest, Inc.
12.1.2. Actylis
12.1.3. Amadis Chemical Company Limited
12.1.4. American International Chemical, LLC
12.1.5. Bioneer Corporation
12.1.6. Biosynth Ltd.
12.1.7. BOCSCI Inc.
12.1.8. ChemGenes Corporation
12.1.9. Creative Biolabs
12.1.10. Hongene Biotech Corporation
12.1.11. Huaren Science and Technology Co., Ltd.
12.1.12. Integrated DNA Technologies, Inc. by Danaher Corporation
12.1.13. LGC Limited
12.1.14. Lumiprobe Corporation
12.1.15. Maravai LifeSciences
12.1.16. MedChemExpress
12.1.17. Merck KGaA
12.1.18. PolyOrg, Inc.
12.1.19. QIAGEN N.V.
12.1.20. SBS Genetech Co., Ltd.
12.1.21. STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
12.1.22. Thermo Fisher Scientific Inc.
12.1.23. Tokyo Chemical Industry Co., Ltd.
12.1.24. Twist Bioscience Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
FIGURE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHOSPHORAMIDITE MARKET DYNAMICS
FIGURE 7. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings